Nycomed Goes Global with Contiki

Pharmaceutical giant Nycomed has signed an agreement that moves CMA Contiki's Enterprise Contract Management system from  local to global level. 

Nycomed operates throughout Europe and in fast-growing markets such as Latin America, Russia/CIS and the Asia-Pacific region.  The global roll-out of Contiki ECM will give them the opportunity to capitalise on the contract management success they have experienced in Scandinavia.

Says Lars Robertsen, Contiki's Pharmaceutical Executive:

"We are pleased to finally be able to move forward to a global level with Nycomed.  We are confident that the Contiki Enterprise Contract Management system will perform above and beyond their expectations."

 

About Nycomed

Nycomed is a privately owned pharmaceutical company that provides medicines for hospitals, specialists and general practitioners, as well as over-the-counter medicines in selected markets.

The company is active in a range of therapeutic areas. Its key products are aimed at gastroenterology, pain management, osteoporosis, respiratory diseases and tissue management. New products are sourced both from our own research and from business partners.

Operating throughout Europe and in fast-growing markets such as Latin America, Russia/CIS and the Asia-Pacific region Nycomed has a presence in about 50 markets worldwide.

The combined group employs over 11,500 people. In 2007, it had annual sales of € 3.5 billion and an adjusted EBITDA of € 1.2 billion.

For more information visit www.nycomed.com